India's Leading Pharmaceutical Company
Our R&D is set to facilitate the development of pharmaceutical formulations and to cater to the needs of the global clientele of Bafna Pharma. Inaugurated at the hands of Shri Mike Nithavrianakis, British Deputy High Commissioner to Southern India, the R&D facility, is a state-of-art facility for formulation development and analytical development and is designed and equipped to meet the stringent international standards. This new facility is in complete compliance with cGMP, cGLP & ICH guidelines in conducting the R&D activities along with full regulatory compliance to EU-DMF and US-DMF.
With advanced R&D equipments, testing instruments and process control facilities, the R&D center is equipped to manufacture new products from laboratory scale to validation batches. The R&D center has qualified and competent research scientists, who have developed many innovations in the manufacture of formulations, to meet the various requirements of the global market. We strongly believe that with the launch of the new R&D centre we will significantly elevate our efforts in enhancing and developing new products and exceed our customer expectations.
The R&D facility has in-depth exposure to literature search, patent search and preparation of pre-formulation Studies; to conduct analysis on new prototype formulations and to check the feasibility of the product; Development and Optimization of Formula; process improvement; Preparation of Stability batches; Accelerated stability studies and many more intricacies in the formulation development. The overall operations by the R&D will have a direct impact on the commercial manufacturing batches, costing and in providing utmost satisfaction to Bafna Pharma’s customers worldwide.
Through this facility, Bafna will file dossiers for the ever growing, US, UK, Australia and the European Markets and ever emerging RoW markets. This facility will offer a one-stop solution right from development to formulation to dossier making to commercial production and in the long run, the facility is going to be a completely independent profit-making center. The overall objective of this facility is to develop the pharmaceutical products on Contract basis and to design and develop the products indigenously for the ever-expanding Pharma market. This facility will propel to the realization of our mission of achieving INR 5000 million by 2013.